Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS)

Julie Scott, DNP
Julie Scott, DNP
Laugier-Hunziker Syndrome |cancerGO

What is Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS) is a rare disorder that affects the pigment of the skin and mucous membranes of the mouth. LHS is also known as idiopathic lenticular mucocutaneous pigmentation.

LHS is a benign (non-cancerous) condition and does not cause any serious health problems. The main symptom of LHS is the appearance of dark pigmentation on the lips, inside of the mouth, and sometimes on the fingers and toes. The pigmentation is typically brown or black and appears as small, flat spots or patches.

Causes:

The exact cause of LHS is unknown, but it is thought to be a combination of genetic and environmental factors. Some cases of LHS have been associated with mutations in the TERT gene, which is involved in the process of cell division and aging. Other cases have been linked to exposure to certain medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies.

Diagnosis:

LHS is usually diagnosed based on the pigmentation pattern which is characteristic of the disorder, as well as a thorough medical history. In some cases, a skin biopsy may be performed to rule out other conditions that may cause similar symptoms.

Treatment:

Treatment for LHS is usually not necessary as the condition does not cause any health problems. However, if the pigmentation is causing cosmetic concerns, treatment options such as laser therapy, cryotherapy, and topical creams may be considered.

It is important to note that LHS does not increase the risk of developing skin cancer or other health problems. However, it is still important to practice good sun protection habits, such as wearing protective clothing and sunscreen, to prevent damage to the skin

 

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
The future of early detection- Liquid biopsy
November 7, 2022

Cancer is a frightening disease that impacts many people worldwide, a molecular disorder characterized by the corruption of genetic information at the cellular level, with consequences resulting in changes to critical proteins and molecular circuits. While many treatment options are available, early detection is key to successful treatment; liquid biopsies…

Vino Cherian

administrator

Articles
The advances in melanoma staging and treatment
November 8, 2022

Melanoma Staging Once a diagnosis of melanoma has been made, the oncologist may order imaging studies to see if melanoma has spread to other areas of the body. Melanoma is staged from stage 0 to IV, with melanoma becoming more advanced the higher the stage.  When the biopsy has resulted…

Julie Scott, DNP

author

Articles
Endometrial cancer treatments
November 8, 2022

Endometrial cancer treatment The exact treatment prescribed for you will be based on the stage and characteristics of your endometrial cancer. It's important to talk to your oncology team if you have any specific questions about your particular treatment.  Treatment is often classified into local therapy or systemic therapy. Local…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice